MRKMerck & Co., Inc.
AI adoption · Q1 2026 earnings call
Health CarePiloting
4
extracted from this call
3 / 5
operational, no hard numbers
Not disclosed
no breakout in this call
AI was mentioned briefly but substantively by CEO Rob Davis in prepared remarks, framed as an accelerant to Merck's ongoing transformation. Three specific AI-related partnerships were announced or referenced: a multiyear deal with Google Cloud for advanced AI, data, and agentic capabilities; an expanded collaboration with Tempus AI for precision oncology; and an agreement with Mayo Clinic for clinical insights and genomic data. No financial quantification of AI investments or outcomes was provided, and no analyst questions addressed AI directly.
Adopter
See full leaderboard →33/ 100
51
stage: piloting · max spec: 3
0
no quantified disclosure
65
2 scopes
internal_useproduct_embedded
4 AI mentions from this call.
Extracted verbatim from the MRK Q1 2026 earnings call transcript. Speaker, section, and specificity tier surfaced for each mention.
- T3Prepared remarks· CEO· Internal use
“we announced a multiyear partnership with Google Cloud to scale advanced AI, data and agentic capabilities across our company.”
— Robert Davis, MRK earnings callGoogle Cloud - T2Prepared remarks· CEO· Internal use
“as well as a recent agreement with the Mayo Clinic that will allow us to leverage Mayo's clinical insights and genomic data sets at scale.”
— Robert Davis, MRK earnings callMayo Clinic - T2Prepared remarks· CEO· Product-embedded AI
“This complements our recently expanded collaboration with Tempus AI designed to advance our precision oncology strategy”
— Robert Davis, MRK earnings callTempus AI - T1Prepared remarks· CEO· Internal use
“Together, these efforts support improved productivity across our organization and create a real opportunity to advance the innovation in our pipeline with greater speed and with a higher likelihood of ultimately reaching patients.”
— Robert Davis, MRK earnings callGoogle Cloud, Tempus AI, Mayo Clinic
What management wouldn’t quantify.
Analyst questions where management declined to share a specific number. The pattern of refusals is often as informative as the disclosures.
- No financial quantification provided for the Google Cloud multiyear AI partnership (deal size, annual commitment, or capex allocation not disclosed).
- No quantification of the Tempus AI collaboration terms or financial commitment.
- No quantification of the Mayo Clinic agreement scope or financial terms.
- No metrics provided on AI-driven productivity gains, headcount impact, or pipeline acceleration outcomes.
- No analyst questions were asked about AI partnerships or AI strategy, so no opportunity for management to elaborate or be pressed for specifics.
- The nature of 'agentic capabilities' referenced in the Google Cloud deal was not elaborated upon.
Compare with peers.
Other companies in the same sector and at the same AI adoption stage.
Same GICS sector, all stages
Independent research, direct to your inbox.
Live data tracking and analysis. Deep research that cuts through consensus. Evidence-backed insights.